Condition: Generalized Anxiety Disorder · Sponsor: Intra-Cellular Therapies, Inc.
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This is a multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of ITI-1284 as monotherapy treatment in patients meeting Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) criteria for GAD in patients who have had inadequate response to generalized anxiety disorder treatment.
This description comes directly from the study's public registry record.
ITI Clinical Trials · 6464409333 · ITCIClinicalTrials@itci-inc.com
Always discuss trial participation with your own doctor first.
| Clinical Site | Birmingham, Alabama, United States | Recruiting |
| Clinical Site | Little Rock, Arkansas, United States | Recruiting |
| Clinical Site | Rogers, Arkansas, United States | Recruiting |
| Clinical Site | Culver City, California, United States | Recruiting |
| Clinical Site_2 | Encino, California, United States | Recruiting |
| Clinical Site | Encino, California, United States | Recruiting |
| Clinical Site | Los Angeles, California, United States | Recruiting |
| Clinical Site | Oceanside, California, United States | Recruiting |
| Clinical Site | Sherman Oaks, California, United States | Recruiting |
| Clinical Site | Upland, California, United States | Active Not Recruiting |
| Clinical Site | Walnut Creek, California, United States | Recruiting |
| Clinical Site | Farmington, Connecticut, United States | Recruiting |
+ 48 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.